These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 5571456)

  • 1. Hypercalcaemia in patients with advanced mammary cancer.
    Galasko CS; Burn JI
    Br Med J; 1971 Sep; 3(5774):573-7. PubMed ID: 5571456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of malignant hypercalcaemia in carcinoma of the breast.
    Percival RC; Yates AJ; Gray RE; Galloway J; Rogers K; Neal FE; Kanis JA
    Br Med J (Clin Res Ed); 1985 Sep; 291(6498):776-9. PubMed ID: 3929936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin.
    Ralston SH; Alzaid AA; Gardner MD; Boyle IT
    Br Med J (Clin Res Ed); 1986 Jun; 292(6535):1549-50. PubMed ID: 3087513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the renal and skeletal actions of calcitonin in the treatment of severe hypercalcaemia of malignancy.
    Hosking DJ; Gilson D
    Q J Med; 1984; 53(211):359-68. PubMed ID: 6484118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catecholamines cause the hypercalciuria and hypercalcaemia in phaeochromocytoma and in hyperthyroidism.
    Skrabanek P
    Med Hypotheses; 1977; 3(2):59-62. PubMed ID: 331032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis and management of cancer associated hypercalcaemia.
    Ralston SH
    Cancer Surv; 1994; 21():179-96. PubMed ID: 8564993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercalcaemia and malignancy.
    Heath DA
    Ann Clin Biochem; 1976 Nov; 13(6):555-60. PubMed ID: 1015787
    [No Abstract]   [Full Text] [Related]  

  • 8. Thyrotoxic hypercalcaemia treated with porcine calcitonin.
    Buckle RM; Mason AM; Middleton JE
    Lancet; 1969 Jun; 1(7606):1128-30. PubMed ID: 4181605
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypercalcaemia and breast cancer--an increased humoral component in patients with liver metastases.
    Coleman RE; Fogelman I; Rubens RD
    Eur J Surg Oncol; 1988 Oct; 14(5):423-8. PubMed ID: 2846366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone related protein and hypercalcaemia in breast cancer.
    Bundred NJ; Ratcliffe WA; Walker RA; Coley S; Morrison JM; Ratcliffe JG
    BMJ; 1991 Dec; 303(6816):1506-9. PubMed ID: 1782489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow up of breast cancer patients treated for hypercalcaemia with aminohydroxypropylidene bisphosphate (APD).
    Grutters JC; Hermus AR; de Mulder PH; Beex LV
    Breast Cancer Res Treat; 1993; 25(3):277-81. PubMed ID: 8369528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercalcaemia of melanoma: incidence, pathogenesis and therapy with bisphosphonates.
    des Grottes JM; Dumon JC; Body JJ
    Melanoma Res; 2001 Oct; 11(5):477-82. PubMed ID: 11595884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignancy-associated hypercalcaemia: relationship between mechanisms of hypercalcaemia and response to antihypercalcaemic therapy.
    Ralston SH; Gardner MD; Jenkins AS; McKillop JH; Boyle IT
    Bone Miner; 1987 May; 2(3):227-42. PubMed ID: 2974309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stilboestrol diphosphate in hypercalcaemia due to parathyroid carcinoma.
    Sigurdsson G; Woodhouse NJ; Taylor S; Joplin GF
    Br Med J; 1973 Jan; 1(5844):27-8. PubMed ID: 4683634
    [No Abstract]   [Full Text] [Related]  

  • 15. Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy.
    Ralston SH; Fogelman I; Gardiner MD; Boyle IT
    Br Med J (Clin Res Ed); 1984 May; 288(6428):1405-8. PubMed ID: 6426577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival in breast cancer patients after the first episode of hypercalcaemia.
    Kristensen B; Ejlertsen B; Mouridsen HT; Loft H
    J Intern Med; 1998 Sep; 244(3):189-98. PubMed ID: 9747741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radioimmunologic determination of plasma parathormone in hypercalcemia caused by cancer with osseous metastases].
    Lemaire V; Gueris J; Cassou M; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1977 Dec; 44(12):709-13. PubMed ID: 609875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current management of malignant hypercalcaemia.
    Stevenson JC
    Drugs; 1988 Aug; 36(2):229-38. PubMed ID: 3053127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anastrozole can cause severe hypercalcaemia mimicking primary hyperparathyroidism.
    Järhult J
    Breast Cancer; 2014 May; 21(3):379-81. PubMed ID: 21290264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium metabolism in cancer. Studies using calcium isotopes and immunoassays for parathyroid hormone and calcitonin.
    Coombes RS; Ward MK; Greenberg PB; Hillyard CJ; Tulloch BR; Morrison R; Joplin GF
    Cancer; 1976 Nov; 38(5):2111-20. PubMed ID: 186180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.